The company doses first patient in US study of Deraphan, as Dolby Ventures joins €53M Series B to support neuropsychiatric innovation
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
A triple-action Formula for comprehensive respiratory relief
EBITDA for the quarter is Rs. 21.6 crore as against Rs. 18.1 crore in Q2 FY24
Wanbury receives CEP approval from EDQM for launch of Dextromethorphan API
Chericof 12, the first prescription cough syrup in India which gives relief for up to 12 hours, is manufactured using Polistirex technology for sustained release of the drug
Subscribe To Our Newsletter & Stay Updated
